2seventy bio, Inc. (TSVT) Tops Q2 EPS by 121c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q2 EPS of $0.45, $1.21 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $8.97 million versus the consensus estimate of $11.08 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Creatd files Form S-1 and reports Q1 2026 financial results